Full Press Release Details
FRANKLIN LAKES, N.J.,April 28, 2026/PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.05 per common share, payable on June 30, 2026, to holders of record on June 9, 2026. The indicated annual dividend rate is $4.20 per share.
About BDBD is one of the world's largest pure-play medical technology companies with a Purpose ofadvancing the world of health™by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visitbd.comor connect with us on LinkedIn atwww.linkedin.com/company/bd1/, X@BDandCoor Instagram@becton_dickinson.
| Contacts: | |
| Media | Investors |
| Matt Marcus | Shawn Bevec |
| VP, Public Relations | SVP, Investor Relations |
| [email protected] | [email protected] |
Contacts:
Media
Investors
Matt Marcus
Shawn Bevec
VP, Public Relations
SVP, Investor Relations
[email protected]
[email protected]
SOURCE BD (Becton, Dickinson and Company)